Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Zevra Therapeutics Inc., 3 years.
Zevra Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | Zevra Therapeutics Inc. | Option exercise | +12,300 | $4.97 | $61,131 |
| Aug 10, 2026 | Zevra Therapeutics Inc. | Open-market sale | −12,300 | $11.25 | $138,377 |
| Mar 28, 2025 | Zevra Therapeutics Inc. | Open-market purchase | +300 | $7.84 | $2,352 |
| Oct 11, 2024 | Zevra Therapeutics Inc. | Open-market purchase | +500 | $7.92 | $3,960 |
| Jun 23, 2023 | Zevra Therapeutics Inc. | Open-market purchase | +275 | $5.95 | $1,636 |
| Jun 9, 2023 | Zevra Therapeutics Inc. | Open-market purchase | +325 | $5.52 | $1,794 |
| May 30, 2023 | Zevra Therapeutics Inc. | Open-market purchase | +400 | $5.11 | $2,044 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.